December 2022: Biotechnology Medical Technology Health Technology Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Biotechnology Funding Volume (€m) 0 Trend Medical Technology Funding Volume (€m) 0 Trend ... Read more The post Venture Capital Sentiment Tracker – January 2023 appeared first on FCF Fox Corporate Finance GmbH ..read more

FCF Fox Corporate Finance GmbH is pleased to publish the new “FCF Interest & Corporate Loan Monitor Q4/2022”. FCF regularly conducts comprehensive research regarding the German corporate loan and interest market, based on publically available ... Read more The post FCF Interest & Corporate Loan Monitor Q4/2022 published appeared first on FCF Fox Corporate Finance GmbH ..read more

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 12/2022”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As ... Read more The post FCF Biotech Venture Capital Monitor – USA 12/2022 published appeared first on FCF Fox Corporate Finance GmbH ..read more

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF European Infrastructure & Construction Market Study – 2022”. Based on available data from European infrastructure and construction companies, the FCF Infrastructure & Construction ... Read more The post FCF European Infrastructure & Construction Market Study 2022 – published appeared first on FCF Fox Corporate Finance GmbH ..read more

The post FCF is sponsor of the 7th ECP on February 23-24, 2022 in Düsseldorf, Germany appeared first on FCF Fox Corporate Finance GmbH ..read more

FCF Fox Corporate Finance GmbH advised German Bionic on a venture debt financing Munich, January 24, 2023 – The European Investment Bank (EIB) has invested EUR 15 million in the form of a venture debt ... Read more The post FCF Fox Corporate Finance GmbH advised German Bionic on a venture debt financing appeared first on FCF Fox Corporate Finance GmbH ..read more

December 2022: Biotechnology Medical Technology Health Technology Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Biotechnology Funding Volume (€m) 0 Trend Medical Technology Funding Volume (€m) 0 Trend ... Read more The post Venture Capital Sentiment Tracker – December 2022 appeared first on FCF Fox Corporate Finance GmbH ..read more

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 12/2022”. The Monitor is a monthly published overview of venture capital trends in the European Life Sciences ... Read more The post Life Sciences Venture Capital Monitor – Europe 12/2022 published appeared first on FCF Fox Corporate Finance GmbH ..read more

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Bank Monitor – Q3 2022”. FCF regularly engages in research on the banking sector based on available data from the most active and ... Read more The post FCF Bank Monitor – Q4 2022 published appeared first on FCF Fox Corporate Finance GmbH ..read more

The ever-increasing venture capital funding for European life sciences companies halted in 2022. With a roughly EUR 9.6bn volume, the overall financing for European life sciences companies in 2022 decreased significantly compared to 2021 (EUR ... Read more The post Venture capital funding in 2022 significantly decreased compared to 2021 appeared first on FCF Fox Corporate Finance GmbH ..read more